Nexentis Technologies Inc. NXTS 深 滬
已收盤 05-08 16:00:00 美东时间
5.11
-0.740
-12.65%
華盛通- 最 高5.48
- 今 開5.35
- 成交量 3.86万股
- 最 低 4.58
- 昨 收 5.85
- 總市值 373.26万
- 52周最高 109.0005
- 市盈率 靜 --
- 換手率 5.28%
- 52周最低 3.8724
- 委 比 30.92%
- 總股本 73.05万
- 歷史最高 18865.00
- 量 比 0.57
- 振 幅 15.38%
- 歷史最低 3.8724
- 每 手 1
- 風險率 25.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nexentis Technologies' Subsidiary Receives U.S. Patent And Trademark Office Official Trademark Registration For Its MITOLINE Algorithm Platform
Nexentis Technologies Inc. (NASDAQ:NXTS), ("Nexentis" or the "Company"), a drug discovery company that is also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced that its
05-05 19:49
Nexentis Rebalances Portfolio with Voice Assist Equity Stake
The latest announcement is out from Nexentis Technologies ( ($NXTS) ). On Janua...
03-18 04:40
Nexentis Technologies Announces Launch Of Its New Corporate Website At www.nexentistech.com
Nexentis Technologies Inc. (NASDAQ:NXTS), ("Nexentis" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, is proud to announce
03-13 21:18
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
Nexentis Technologies Inc. launched its new corporate website, www.nexentistech.com, following a rebranding from N2OFF, Inc. The website highlights the company's focus on mitochondrial biology for precision oncology and inflammatory metabolic diseases, showcasing its MITOLINE™ discovery engine and MitoCareX Bio Ltd. subsidiary. Nexentis also invests in solar energy assets through the RTB (Ready-to-Build) model and controls Save Foods Ltd., specia...
03-13 13:15
